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Two-component flavoprotein monooxygenases are emerging biocatalysts that generally consist of a mono-
oxygenase and a reductase component. Here we show that Rhodococcus opacus 1CP encodes a multifunctional
enantioselective flavoprotein monooxygenase system composed of a single styrene monooxygenase (SMO)
(StyA1) and another styrene monooxygenase fused to an NADH-flavin oxidoreductase (StyA2B). StyA1 and
StyA2B convert styrene and chemical analogues to the corresponding epoxides at the expense of FADH2
provided from StyA2B. The StyA1/StyA2B system presents the highest monooxygenase activity in an equimolar
ratio of StyA1 and StyA2B, indicating (transient) protein complex formation. StyA1 is also active when FADH2
is supplied by StyB from Pseudomonas sp. VLB120 or PheA2 from Rhodococcus opacus 1CP. However, in both
cases the reductase produces an excess of FADH2, resulting in a high waste of NADH. The epoxidation rate of StyA1
heavily depends on the type of reductase. This supports that the FADH2-induced activation of StyA1 requires
interprotein communication. We conclude that the StyA1/StyA2B system represents a novel type of multifunctional
flavoprotein monooxygenase. Its unique mechanism of cofactor utilization provides new opportunities for biotech-
nological applications and is highly relevant from a structural and evolutionary point of view.
The environmentally harmful hydrocarbon styrene is readily
biodegradable by various classes of microorganisms covering
Gram-negative and Gram-positive bacteria as well as fungi
(e.g., ascomycetes). Two major pathways for styrene mineral-
ization have been described (reviewed in references 23, 26, and
33); of these, the most common one is initiated by a mono-
oxygenase-catalyzed epoxidation of the vinyl side chain. Due to
their biotechnological potential, the styrene monooxygenases
(SMOs) involved in this reaction have received considerable
attention. Most SMOs have been described for pseudomonads
and were investigated for their biochemical properties (5, 13,
27, 31, 46) and their biotechnological applicability in cell-free
(16, 17) or whole-cell systems (3, 12, 28, 29, 30, 32, 37). All
SMOs investigated thus far convert styrene in a highly enanti-
oselective manner to (S)-styrene oxide, which is a useful pre-
cursor for several chiral synthons and pharmaceuticals (2, 6,
14, 26, 34). Moreover, the relaxed substrate specificity of
SMOs allows an enantioselective conversion of substituted sty-
rene derivatives and structurally related compounds, like in-
dene and dihydronaphthalene, as well as phenylalkylsulfides
(Fig. 1) (17, 40, 45), thus increasing their biocatalytic potential.
Typical SMOs of pseudomonads consist of two enzymati-
cally active protein components encoded by genes that are
usually clustered adjacent to each other (styA and styB) (Fig.
2a) (26, 43, 46). The flavin reductase subunit (StyB) reduces
flavin adenine dinucleotide (FAD) at the expense of NADH.
The monooxygenase subunit (StyA) then utilizes the reduced
flavin (FADH2) to activate molecular oxygen for styrene attack
(Fig. 2b). The mechanism of FAD transfer between StyB and
StyA is not yet fully understood. In vitro, StyB can be replaced
by different flavin reductases from other organisms (e.g., oxi-
doreductases from Photobacterium fischeri or Geobacillus ther-
moglucosidasius) (27, 45), or FADH2 can be supplied electro-
chemically (16, 17). In both cases, StyA shows no significant
loss in epoxidation capacity, indicating that no specific protein-
protein interactions are needed for FADH2 transfer. Indica-
tions for a protein contact-based transfer of FADH2 were
found by kinetic studies (19) and have also been proposed for
other two-component flavoprotein monooxygenases (9, 10).
Efficient interprotein transfer of the flavin cofactor will prevent
FADH2 autooxidation and limit oxidative stress (21, 22). Pre-
venting such stress is highly relevant for the biotechnological
applicability of multicomponent oxygenases since it can se-
verely improve long-term stability of whole-cell as well as cell-
free transformation processes.
An evolutionary strategy to overcome transport-based limi-
tations is the generation of self-sufficient fusion proteins (24,
35, 38). The hemoflavoprotein P450 BM3 from Bacillus mega-
terium is a well-known prototype, and its high oxygenation
efficiency has triggered activities of protein engineering in or-
der to construct novel protein chimers by gene fusion (24, 25,
41). Recently, we reported on the identification of the first
self-sufficient styrene monooxygenase from the nocardioform
actinobacterium Rhodococcus opacus 1CP (40). This novel en-
zyme (StyA2B) harbors a monooxygenase and reductase unit
in one polypeptide chain. The recombinant protein was bio-
chemically characterized showing similar substrate specificity
and enantioselectivity levels compared to those of two-com-
ponent SMOs. However, the specific activity of the StyA2
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oxygenase unit was found to be rather low. This observation
contradicts the above-mentioned notion of a high-perfor-
mance monooxygenase. A closer look at the genetic local-
ization of styA2B indicated the presence of an open reading
frame (styA1) encoding another putative styrene monooxy-
genase (Fig. 2a). Interestingly, a similar open reading frame is
present directly upstream of other fused SMO genes in the
genomes of Nocardia farcinica IFM10152 and Arthrobacter au-
rescens TC1 (40, 45). This structural conservation and feasibil-
ity of cotranscription may indicate a functional dependency
(Fig. 2b). To address this issue, we studied the catalytic prop-
erties of the StyA1/StyA2B system. Our data indicate that this
styrene-oxygenating system represents an unprecedented type
of two-component flavoprotein monooxygenase.
MATERIALS AND METHODS
Chemicals and enzymes. Oxygenation substrates, (S)- and (R)-styrene oxide,
catalase, formate dehydrogenase, and cofactors were purchased from Sigma-
Aldrich (Steinheim, Germany) and Carl Roth (Karlsruhe, Germany). Chlorosty-
rene oxides, 4-methylstyrene oxide, and dihydronaphthalene oxide were synthe-
sized, purified, and structurally characterized as described previously (40).
Bacterial strains, plasmids, and culture conditions. The bacterial strains and
plasmids used in this study are listed in Table 1. Escherichia coli BL21 strains
were grown aerobically at 37°C under constant shaking in baffled shaking flasks
with LB medium (100 g ml1 ampicillin or 20 g ml1 kanamycin, and 35 g
ml1 chloramphenicol) (36).
Expression and purification of recombinant StyA1 and StyA2B (R. opacus
1CP). Recombinant His10-StyA2B was expressed and purified as reported pre-
viously (40). The expression of His10-StyA1 was made in a bio-fermenter (7-l-
Bioreactor, ADI 1030 Biocontroller; Applikon). For this purpose, 4 liters LB-
medium (ampicillin and chloramphenicol) was inoculated with 50 ml of a
preculture of E. coli BL21 (pSRoA1_P01), and cultivation was performed at 30°C
(600 rpm, 0.3 standard liters of air per min) up to an optical density at 600 nm
(OD600) of approximately 0.7. Temperature was then gradually decreased to
20°C, and induction was started by adding 0.05 to 0.1 mM IPTG (isopropyl--
D-thiogalactopyranoside). After 26 to 40 h of incubation (20°C), cells were
harvested by centrifugation and disrupted in a precooled French press.
Purification of His10-StyA1 was achieved by Ni-chelate chromatography on a
1-ml HisTrap FF column, using an A¨KTA fast-performance liquid chromatog-
rapher (GE Healthcare). The chromatographic procedure was basically similar
to that for His10-StyA2B. Fractions showing styrene-oxygenating activity were
freed from imidazole and stored at 20°C as described previously (40). The
achieved yields of active soluble His10-StyA1 were rather low, as described in
Results. Attempts (change expression vector, host, or conditions) to improve the
yield and turn expression from insoluble toward soluble protein failed (data not
shown).
Expression, purification, and refolding of recombinant PheA2 (R. opacus
1CP). The oxidoreductase PheA2 is the small component of a flavin-dependent
two-component phenol monooxygenase from R. opacus 1CP (our unpublished
data), and it reduces FAD to FADH2 at the expense of NADH.
The procedure for the expression of recombinant PheA2 was similar to the
above-described procedure for StyA1. A volume of 60 ml overnight culture of E.
coli BL21 Codon Plus RP (pETP7B’1) (our unpublished data) was used as the
inoculum. Cultivation took place at 30°C to an OD600 of 0.6. Induction of the
pET regulatory system was achieved by adding 0.2 mM IPTG, with further
incubation for 20 h at 30°C.
PheA2 was expressed as inclusion bodies and purification/refolding according
to the instructions of the QuickFoldTM protein refolding kit (Athena Environ-
mental Sciences, Inc., Baltimore, MD). Inclusion body pellets resulting from
crude extract preparation were subjected to four washing steps using 50 mM Tris
HCl (pH 8.0), 4 M urea, 0.5 M NaCl, 1 mM EDTA, 0.1% (vol/vol) Triton X-100.
FIG. 2. Schemes for genetic organization and proposed mechanism of StyA/StyB from Pseudomonas sp. VLB120 and StyA1/StyA2B from R.
opacus 1CP. For simplicity, only monomers are shown. (a) For Pseudomonas sp. VLB120, gene cluster encoding the upper styrene degradation
pathway: stySc and styR regulatory genes; styA and styB encoding a styrene monooxygenase, styC encoding a styrene oxide isomerase, and styD
encoding phenylacetaldehyde dehydrogenase (31). For R. opacus 1CP, organization of investigated styrene-catabolic genes: styA1 for putative
oxygenase component of a two-component SMO and styA2B for single-component SMO (40). (b) From left to right, cooperative mechanism of
a typical two-component SMO of Pseudomonas (27), mechanism of the self-sufficient monooxygenase StyA2B of R. opacus 1CP (40), and
hypothetical cooperation between StyA2B and StyA1. The FADH2 surplus of StyA2B is utilized by StyA1, yielding an increase of styrene-
oxygenating activity. Dashed arrows indicate uncoupling-based FADH2 autooxidation leading to the formation of hydrogen peroxide.
FIG. 1. Enantioselective oxygenations catalyzed by styrene mono-
oxygenases (SMOs). Each * indicates a chiral atom in the formed
products.
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Washed pellets were solubilized in 50 mM Tris HCl (pH 8.0), 8 M urea, 10 mM
dithiothreitol (DTT) and incubated at 50°C until completely dissolved. Refolding
of recombinant PheA2 was achieved by diluting 2 mg ml1 solubilized enzyme
dropwise 1:20 into 50 mM Tris HCl (pH 8.5), 240 mM NaCl, 10 mM KCl, 1 mM
EDTA, 0.05% (wt/vol) PEG 4000, 1 mM glutathione reduced, 0.1 mM glutathi-
one oxidized. The solution was carefully mixed by inversion and 20-min incuba-
tion at room temperature. Concentration of refolded protein was achieved by
ammonium sulfate precipitation (80% final saturation). After 2.5 h of incubation
on ice and subsequent centrifugation (20,000  g, 20 min, 4°C), the protein
precipitate was resuspended in 25 mM Tris HCl (pH 7.5), 1 M NaCl, 0.5 mM
MgCl2, and 2 mM DTT and again centrifuged to remove remaining insoluble
protein. Aliquots containing 50% (vol/vol) glycerol were stored at 20°C.
Expression, purification, and refolding of recombinant StyB (Pseudomonas sp.
VLB120). Expression of recombinant StyB was carried out according to Otto and
coworkers (27) with the following modifications: (i) expression was carried out in
shaking flasks with 100 ml to 300 ml LB medium and appropriate amounts of
antibiotics, (ii) E. coli BL21 pLys was used as a host harboring pTEZ302, and (iii)
induction of the alk regulatory system of the expression vector was accomplished
by adding 0.05% (vol/vol) octane instead of dicyclopropylketone. Recombinant
StyB was exclusively expressed as inclusion bodies.
Purification, washing, and refolding procedures of StyB inclusion bodies were
performed as described previously (27). Buffer exchange for storage (25 mM Tris
HCl, pH 7.5, 1 M NaCl, 0.5 mM MgCl2, 0.5 mM DTT) and concentration of the
renaturated protein was performed by means of a stirred ultrafiltration cell (type
8050, volume of 50 ml; Millipore Corp., Bedford, MA) equipped with a YM30
membrane (exclusion limit of 10,000 Da; Millipore). To remove insoluble pro-
tein, the concentrate was centrifuged and the supernatant separated and por-
tioned. After adding glycerol to a final concentration of 5% (vol/vol), refolded
active StyB was stored in aliquots at 20°C.
Protein quantification. Protein concentrations were determined with the
Bradford method (8) using the protein assay reagent (Bio-Rad). Bovine serum
albumin (Sigma) served as a reference protein. Alternatively, His10-StyA2B
concentrations were determined at 280 nm using a NanoDrop photometer
(Peqlab).
Oxidoreductase activity determination. Oxidoreductase activities of StyB from
Pseudomonas sp. VLB120, PheA2 from R. opacus 1CP, and StyA2B from R.
opacus 1CP were determined by measurement of NADH consumption at 340
nm. A typical assay (1-ml total volume) contained 20 mol Tris HCl (pH 7.5),
0.05 to 0.15 mol FAD, and a suitable amount of enzyme. After equilibration at
30°C for 10 min, the reaction was started by addition of 0.175 mol NADH (40).
Oxygenase activity determination. The oxygenase activity of recombinant
StyA1 toward styrene and structurally similar substrates was measured by re-
versed-phase high-pressure liquid chromatography (RP-HPLC)-based quantifi-
cation of the reaction product using the assay system described for StyA2B (40).
Reaction rates (measured at least in triplicate) were determined from the initial
slope of product formation, and relative velocities were calculated by referring
the obtained specific activities to that for styrene (100%). From kinetic data, a
standard error of 20% was observed. To regenerate trapped oxygen from
hydrogen peroxide formed via uncoupling of the reductase-oxygenase system,
catalase (650 U, from bovine liver) was added to all assays. Additionally, this
prevents the SMOs from oxidative inactivation by hydrogen peroxide (40).
Formation of epoxides by means of whole-cell biotransformation. Induced
cells of E. coli BL21 (pSRoA2B_P01 or pSRoA1_P01) were harvested by cen-
trifugation and were resuspended in 27 mM sodium-potassium phosphate (pH
7.3) to give a final OD600 of 20. Conversion of 1 mM styrene or 4-chlorostyrene
to the corresponding oxides, solvent extraction of products, and concentration of
combined organic phase was performed as described elsewhere (40). The final
preparation of about 50 l was analyzed by chiral HPLC.
Analysis of chiral products (HPLC). Products from SMO oxygenations were
analyzed by reversed-phase HPLC on a vertex column packed with Eurospher
C18 (125-mm length by 4-mm internal diameter [i.d.], 5-m particle size, 100-Å
pore size; Knauer, Germany) as described previously (40). Additional experi-
ments in order to separate (R)- and (S)-styrene oxide on a Nucleodex alpha-PM
column (250-mm length by 4-mm i.d.; Macherey-Nagel, Germany) were per-
formed in isocratic mode (40% [vol/vol] methanol; 0.1% [vol/vol] triethyl am-
monium acetate [TEAA], pH 4.0; 0.7 ml min1) (40).
The chromatographic behavior of products was outlined previously, except for
2-chlorostyrene oxide (net retention volume, 3.05 ml; 60% [vol/vol] acetonitrile)
and 3-chlorostyrene oxide (2.76 ml; 60% [vol/vol] acetonitrile). Retention vol-
umes as well as UV spectra (200 to 400 nm) of all products were compared to
those of authentic standards. Absorbance at 210 nm was used for quantification
and referred to multipoint calibrations of standards.
Detection of protein-bound flavins. The content and identity of noncovalently
bound flavin in StyA1 and StyA2B was determined by RP-HPLC (39). For that
purpose, 35 l of 3 mg ml1 purified protein in 20 mM Tris HCl (pH 7.5) was
treated with trichloroacetic acid (TCA) (final concentration, 75 mg ml1), and
after centrifugation (16,000  g, 5 min, 4°C), the protein-freed supernatant was
neutralized with 0.8 M K2HPO4. This sample containing the extracted flavin was
subjected to a Eurospher C18 column (250-mm length by 4-mm i.d., 5-m
particle size, 100-Å pore size; Knauer, Germany). RP-HPLC was performed with
50 mM sodium acetate (pH 5.0), and flavins were eluted with a linear gradient of
30% to 60% methanol (flow, 0.7 ml min1). A multipoint calibration for each
flavin species was measured with authentic standards (net retention volume: 2.8
ml FAD, 4.3 ml flavin mononucleotide [FMN], 8.4 ml riboflavin) in a range from
0.25 M to 25 M. A similar control experiment was performed with bovine
serum albumin (Roth).
Dissociation constants of apoenzyme-flavin complexes. The apo forms of
StyA1 and StyA2B were prepared by gel filtration (Bio-Gel P-6, 10 ml; Bio-Rad)
using 50 mM Tris HCl (pH 7.5). Dissociation constants of protein-flavin com-
plexes were determined from tryptophan fluorescence titration experiments
(Cary Eclipse fluorescence spectrometer; Varian). Each apoenzyme (0.5 to 1.0
M) was titrated at 15°C with 0 to 10 M FAD following the tryptophan
fluorescence signal at 340 nm from excitation at 290 nm (about 30 data points per
titration step; standard error of 1%). The dissociation constants (Kd) for the
apoenzyme-flavin complexes were obtained by fitting the fluorescence (F) over
added flavin with a scaled Levenberg-Marquardt algorithm according to Bollen
and coworkers (7).
Determination of protein size and subunit organization. Discontinuous SDS-
PAGE on 12% slab gels was performed to prove purity as well as subunit size of
purified samples (36). Protein markers of the PagerRuler series (10 to 200 kDa;
Fermentas) were used for size estimation. Proteins were checked for covalently
bound flavins by fluorescence analysis after SDS-PAGE (39). The size of native
His10-StyA1 was determined by size exclusion chromatography using a Superdex-
200 HR16/60 column (GE Healthcare) running in 100 mM Tris HCl (pH 7.5),
150 mM NaCl. A low- and high-molecular-weight reference protein kit (Amer-
sham Pharmacia) was used for size calibration.
Nucleotide sequence accession number. The 8,965-bp genomic fragment in-
cluding the genes styA1 and styA2B from R. opacus 1CP has been deposited at
GenBank under accession no. FJ403049 (40). The pheA2 sequence from strain
1CP has been deposited at GenBank under accession no. FN908432.
RESULTS
Expression and hydrodynamic properties of recombinant
StyA1. Recombinant His10-StyA1 was expressed in E. coli
(pSRoA1_P01) mainly in the form of inclusion bodies. Active
soluble protein (about 7.5 mg final yield) was obtained from a
4-liter bioreactor culture by keeping the temperature during
TABLE 1. Strains and plasmids
Strain or plasmid Relevant characteristic(s) Source or reference
E. coli BL21(DE3) (pLysS) hsdS gal (cIts857 ind1 Sam7 nin5 lacUV5-T7 gene 1), pLysS (Cm) Stratagene
E. coli BL21 Codon Plus RP F ompT hsdS(rB
 mB
) dcm	 Tetr gal endA Hte 
argU proL Camr Stratagene
pSRoA2B_P01 styA2B of R. opacus 1CP (1.722-kb NdeI/NotI-fragment) cloned in pET16bP 40
pSRoA1_P01 styA1 of R. opacus 1CP (1.221-kb NdeI/NotI-fragment) cloned in pET16bP 40
pTEZ302 pSPZ2 Not derivative harboring styB (Pseudomonas sp. VLB120) 27
pETP7B’1 pET-derivative harboring pheA2 (R. opacus 1CP) Unpublished
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growth phase at 30°C and by decreasing the temperature be-
fore induction to 20°C. SDS-PAGE of Ni-chelate-purified
His10-StyA1 showed a single protein band with an expected
molecular mass of 44 kDa (not shown; theoretical molecular
weight [MW], 46,537). No covalently bound flavin was detected
via fluorescence analysis after SDS-PAGE separation. Elution
behavior of the native protein during size exclusion chroma-
tography pointed to a hydrodynamic size of 80  5 kDa, which
corresponds to a homodimer. A similar native structure was
reported for StyA from Pseudomonas sp. VLB120 (27) and for
StyA2B from R. opacus 1CP (40).
Expression and purification of other monooxygenase com-
ponents. Recombinant His10-StyA2B showed a comparable
FAD-reducing activity (3.3 U mg1) and styrene oxygenase
activity (0.02 U mg1) after purification as previously de-
scribed (40). Recombinant PheA2 from R. opacus 1CP, initially
obtained as inclusion bodies, could be refolded to the active
form with a specific FAD reductase activity of 20.7 U mg1.
The protein yielded a single band of about 17 kDa during
SDS-PAGE and behaved as a homodimer in gel filtration. The
recombinant StyB from Pseudomonas sp. VLB120 was success-
fully expressed, purified, and refolded as described elsewhere
(27). With a specific FAD-reducing activity of 60 U mg1, StyB
appeared to be the most active reductase applied in this study.
Identification of the capability of StyA1 for styrene epoxi-
dation. Sequence analysis of StyA1 from R. opacus 1CP re-
vealed the highest similarities to several oxygenases of two-
component styrene monooxygenases from pseudomonads (40).
A gene coding for a single flavin reductase component could
not be identified close to styA1, an arrangement which is typical
for these genes in pseudomonads (Fig. 2a) (26). Instead, an
adjacent styB gene is part of styA2B (Fig. 2a), which encodes a
self-sufficient SMO (40). Thus, the monooxygenase StyA1
might retrieve FADH2 from StyA2B, enabling its styrene ep-
oxidation activity (Fig. 2b). Detection of StyA1 activity in the
presence of StyA2B needs special consideration in view of the
oxygenase activity of bifunctional StyA2B. Therefore, we
independently determined the oxygenase activity of StyA1 in
the presence of the StyB reductase from Pseudomonas sp.
VLB120. This approach was chosen since the specificity
between oxygenases and FAD reductases seems rather
broad, especially, for SMOs (27, 45).
Equal molar amounts of both proteins (StyA1/StyB) were
subjected to the standard oxygenase assay using styrene as the
oxygenase substrate as well as FAD and NADH as the sub-
strates for StyB. Styrene epoxidation activity of 0.35 U mg1
was determined for His10-StyA1, clearly proving its function as
a monooxygenase. As expected, a lack of StyB prevented any
styrene conversion, whereas a molar StyB/StyA1 ratio of 1:2
did not bring about any loss of StyA1 activity (0.36 U mg1).
This observation reflects the fact that even under these condi-
tions the StyB activity exceeds that of His10-StyA1 (see below)
(Table 2), and a 2-fold molar excess of StyB resulted in a 45%
reduction of the styrene epoxidation rate (0.19 U mg1). This
was most likely caused by the high StyB activity (271 mU)
resulting in overproduction of FADH2, which may act as an
oxygen trap (22). Another explanation would be that StyA1 is
inactivated by the reactive oxygen species generated during the
reoxidation of FADH2 (4, 40).
Activity of StyA1 with different FAD reductases. StyA1 ac-
tivity showed a remarkable dependence on the type of FAD
reductase. Comparison of equimolar ratios of both enzymes
showed the highest activity for the StyA1/StyB system (2.03
mU; this value corresponds to a specific activity of 0.35 U
mg1), followed by StyA1/StyA2B (1.28 mU) and StyA1/
PheA2 (0.09 mU) for 125 pmol of each protein (Table 2).
Reliable epoxidation rates from the last combination were
yielded only from 250 pmol of each component. The combi-
nations of 125 pmol StyA1 and 125 or 250 pmol PheA2 did not
yield a measurable amount of epoxide.
In view of the different specific activities of the reductases,
the term epoxidation efficiency was introduced. This efficiency
indicates the amount of FADH2 cofactor necessary for the
incorporation of one atom of oxygen in the process of styrene
epoxidation. The very low activity of StyA1 in the presence of
equimolar amounts of PheA2 points to a low degree of coop-
eration between these proteins. StyA2B- and StyB-containing
systems with lower or similar FAD-reducing capacities show a
considerably higher epoxidation efficiency with StyA1 (Ta-
ble 2). The StyA1/StyA2B couple is clearly the most efficient
TABLE 2. StyA1 oxygenase activity in dependence of different FAD reductases
FAD reductase Molar amt(pmol)
FAD-reducing
activity (mU)a
StyA1 oxygenase
(molar amt 
pmol)
Epoxidation
activity (mU)a
Relative
activity (%)b
Efficiency of oxygenation
Styrene oxide
per FADH2c
Relative
efficiency (%)b
StyA2B 62.5 13.2 125 0.58 (0.66) 46 0.044 90
125 26.4 1.28 (1.43) 100 0.049 100
250 52.8 1.22 (1.52) 96 0.023 47
StyB 62.5 67.2 125 2.06 161 0.031 63
125 135.5 2.03 159 0.015 31
250 271 1.11 87 0.004 8
PheA2 250 87 250d 0.18 7 0.002 4
a All experiments were performed in triplicate, and for oxygenations, a standard error of 20% was observed. Values in parentheses refer to experimentally obtained
data comprising additional epoxidation activity of bifunctional StyA2B (0.019 U mg1).
b Normalized values set to 100% for equimolar StyA1/StyA2B reaction (for 125 pmol StyA1).
c Efficiency is defined as the ratio of oxygenase-generated epoxide per reductase-generated FADH2.
d With PheA2 as reductase, only higher amounts of StyA1 yielded reliable epoxidation rates.
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epoxidation system, utilizing approximately 20 molecules of
FADH2 for the epoxidation of one molecule styrene. Both
StyA2B surplus as well as StyA2B deficit result in a decrease of
oxygenation activity compared to the equimolar mixture, thus
indicating a highly balanced system. The observation that an
increase of StyA2B does not bring about a further increase of
StyA1 activity suggests that FADH2 transfer is induced by
a direct contact between the monooxygenase components
rather than occurring as free diffusion. In this case, a higher
StyA2B ratio should not lead to remarkable FADH2 over-
production which traps oxygen and limits StyA1 activity,
because StyA2B has rather low FAD-reducing activity com-
pared to StyB (Table 2).
Oxygenation specificity of StyA1. The StyA1/StyA2B system
was studied for its oxygenation specificity. For this purpose,
both enzymes were mixed in equimolar amounts. Under these
conditions, the epoxidation efficiency is maximal and StyA2B
primarily acts as a FAD reductase (Table 2). Epoxidation
was observed with styrene, 2-chlorostyrene, 3-chlorostyrene,
4-chlorostyrene, 4-methylstyrene, and dihydronaphthalene, while
methylphenylsulfide is transformed into a sulfoxide (Table 3).
Like StyA2B, StyA1 is able to convert a number of aromatic
compounds. Comparison of relative StyA1 and StyA2B activ-
ities indicates a distinct selectivity which is especially obvious
from the conversion of methylphenylsulfide, 3-chlorostyrene,
and 2-chlorostyrene. The last compound is not a substrate for
StyA1. As a consequence and depending on the type of sub-
strate, StyA2B contributes different degrees of oxygenation
activity to the StyA1/StyA2B system (Fig. 3). Compared to
StyA2B alone, the StyA1/StyA2B system brings about a 10-fold
increase of activity (with styrene as substrate), showing that the
surplus of the FAD-reducing capacity of StyA2B can be effi-
ciently used by StyA1.
The stereospecificity of StyA1 (enantiomeric excess [e.e.],
96%) is comparable to that of StyA2B (e.e., 94%). Styrene
is converted by both monooxygenases to the (S)-epoxide in a
highly enantioselective manner, a property which is shared by
all SMOs reported so far.
Flavin binding of monooxygenase components. Styrene
monooxygenases contain a Rossmann fold for binding FAD via
its AMP moiety (27, 40, 42). This and the fact that FADH2
transfer is necessary for SMO activity raises the question of the
protein-flavin interaction. TCA precipitation revealed that StyA1
and StyA2B both contain trace amounts of noncovalently bound
FAD (1 to 4 moles percent [mol%]) (Fig. 4a). A similar result
was obtained by spectrophotometrical analysis of StyA2B (40).
This indicates that StyA1 and StyA2B have some affinity for
oxidized FAD, since FAD was never added in any purification
step.
To study the specificity of the protein-flavin interaction in
more detail, the purified StyA1 and StyA2B apoproteins were
titrated with FAD and analyzed for changes in tryptophan
fluorescence. In the case of StyA1, the tryptophan fluorescence
decreased considerably and clear binding of FAD was ob-
served (Fig. 4b). From the titration curve and assuming 1:1
binding (0.59 M StyA1), a Kd value for FAD [Kd(FAD)] of
0.23  0.06 M was estimated for the dissociation constant of
the StyA1-FAD complex. In the case of StyA2B (0.66 M; Fig.
4b), the tryptophan fluorescence decreased also upon FAD
addition, but the curve shapes differed, and the final normal-
ized tryptophan fluorescence was clearly lower than that from
StyA1. This quenching behavior might result from the two
flavin binding sites of StyA2B, one in the reductase and one in
TABLE 3. Oxygenation specificity of StyA1 and other styrene monooxygenases
Substrate/product
Specific oxygenase activity in U mg1 (relative activity %) and, if determined, % enantiomeric excess
(preferred enantiomer) for indicated oxygenase and reductaseb
StyA1 of R. opacus
1CP and StyA2B of
R. opacus 1CPa,c
StyA2B of R.
opacus 1CP and
StyA2B of R.
opacus 1CPc
StyA1 	 StyA2B
of R. opacus 1CP
and StyA2B of R.
opacus 1CPc
StyA of
Pseudomonas sp.
VLB120 and
electrochemical
FAD reductiond
Unknown SMO,
metagenome, and
PheA2 of
Geobacillus
thermoglucosidasiuse
Styrene/styrene oxide 0.214 (100) 96 (S) 0.019 (100) 94 (S) 0.233 (100) 94 (S) 0.204 (100) 98 (S) 0.80 (100) 99 (S)
2-Chlorostyrene/2-chlorostyrene oxide 0.001 (0.1) 0.007 (37) 0.007 (3) ND ND
3-Chlorostyrene/3-chlorostyrene oxide 0.162 (76) 0.044 (232) 0.206 (88) ND ND
4-Chlorostyrene/4-chlorostyrene oxide 0.078 (36) 0.011 (58) 82 0.089 (38) 0.312 (153) 98 0.23 (29) 99 (S)
4-Methylstyrene/4-methylstyrene oxide 0.102 (48) 0.006 (32) 0.108 (46) 0.312 (153) ND
Dihydronaphthalene/dihydronaphthalene oxide 0.171 (80) 0.011 (58) 0.182 (78) 0.376 (184) 99 ND
Methylphenylsulfide/methylphenylsulfoxide 0.325 (152) 0.012 (63) 0.337 (145) 0.226 (111) 26 0.11 (14) 75 (R)
a Values for StyA1 were obtained from total activities of StyA1/StyA2B by subtracting oxygenation rates of StyA2B.
b ND, not determined.
c This study and reference 40.
d Reference 17. A maximum activity of 2.1 U mg1 for the recombinant StyA/StyB system was reported later (27).
e Reference 45.
FIG. 3. Relative substrate specificities of the StyA1/StyA2B system
and the extent of StyA2B oxygenation.
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the oxygenase domain. Assuming one binding site, we esti-
mated a Kd(FAD) of 5.05  0.52 M for the StyA2B-FAD
complex. Assuming two independent binding sites, we esti-
mated the following dissociation constants: Kd1(FAD) of
0.05  0.17 M and Kd2(FAD) of 7.19  0.61 M. These
values have to be taken with care, since cooperativity cannot
be excluded. Furthermore, the very small contribution of the
first binding site (5%) to the total decrease of the tryptophan
fluorescence and the high standard error for Kd1(FAD) indi-
cates another behavior. Thus, the dissociation constants given
herein for StyA2B indicate only the M range of both values.
DISCUSSION
The StyA1/StyA2B system reported herein represents a new
type of FAD-dependent styrene monooxygenase (SMO). Re-
cently, we described StyA2B from R. opacus 1CP as the first
self-sufficient SMO (40). StyA2B comprises both styrene-oxy-
genating and FAD-reducing activity in one polypeptide and
has a substrate pattern similar to those of conventional two-
component SMOs (Table 3). However, the specific activity of
StyA2B is rather low (0.02 U mg1), and the FADH2 formed
by the reductase domain, is inefficiently used by the fused
oxygenase domain. These observations and the fact that an
additional styA1 gene is located directly upstream from styA2B
raised the hypothesis about a functional interaction between
StyA1 and StyA2B (Fig. 2).
The His-tagged StyA1 protein was successfully expressed
in E. coli and appeared to be a homodimer of about 80 kDa.
Activity measurements with StyB from Pseudomonas sp.
VLB120 showed that StyA1 is able to oxidize styrene under
consumption of FADH2. When StyB was replaced by PheA2
from R. opacus 1CP, a drastic decrease in StyA1 activity oc-
curred (Table 2). This is rather surprising because the FADH2
production rate of PheA2 (20.7 U mg1) is similar to that of
StyB (60 U mg1). For the prototype StyA/StyB monooxygen-
ase from Pseudomonas sp. VLB120, it was shown that the StyB
reductase component can be replaced by another FAD reduc-
tase (27) or by an electrochemical reductant (Fig. 2b) (16, 17).
From this it was argued that the FADH2 needed for styrene
epoxidation is provided via free diffusion and that no specific
interaction between StyA and StyB is needed. However, an
equimolar amount of PheA2 achieved only 4 to 7% of StyA1
activity compared to that of assays with StyB or StyA2B. This
suggests that free FADH2 is not feasible for StyA1 and that
efficient epoxidation requires some type of interprotein com-
munication. An alternative, less likely explanation is that the
StyA1 activity is inhibited by PheA2.
With the StyA1/StyA2B system, the highest StyA1 activity
was observed at an equimolar ratio of both components (Table
2). Bisection of the StyA2B amount and therewith reductase
power yielded half of the StyA1 activity. Moreover, a surplus of
the StyA2B amount and a similarly enhanced reductase power
does not increase StyA1 activity. These observations support
the suggestion that StyA1 is not active with free FADH2 and
recognizes StyA2B as its natural partner. Similar transfer
mechanisms based on transient interactions or complex forma-
tion have been proposed for other two-component flavin mo-
nooxygenases (1, 9, 10, 18). Based on the present findings, a
putative StyA1/StyA2B reaction mechanism can be postulated
(Fig. 2b). In this mechanism, both dimeric protein components
form a transient complex in which FADH2 is channeled from
StyA2B toward StyA1, resulting in epoxide formation. As side
reactions, some epoxide is formed in the oxygenase-active site
of StyA2B and H2O2 is produced due to auto-oxidation of
FADH2. This reaction mechanism differs from that of conven-
tional SMOs, especially in FADH2 transfer, since it is induced
by protein cross talk. Nevertheless, it becomes obvious and
must be kept in mind that the system of StyA1/StyA2B de-
scribed herein is still less efficient in flavin transfer since 20
FADH2 molecules are necessary to form one molecule of ep-
oxide (Table 2). Unfortunately, no data for the StyA1/StyA2B
system in the natural host R. opacus 1CP are available.
Binding studies showed that StyA1 and StyA2B interact with
oxidized FAD (Fig. 4). In the case of StyA2B, tryptophan
fluorescence quenching pointed to two FAD binding sites with
FIG. 4. Flavin binding to StyA1 and StyA2B. (a) Purified StyA1
and StyA2B were tested for noncovalently bound flavins by RP-HPLC
as described in Materials and Methods. Bovine serum albumin (BSA)
was used as a blank, and a multipoint calibration for each flavin
standard allowed flavin determination up to a low M range. (b)
Normalized fluorescence emission (F/F0) from tryptophans of StyA1
(0.59 M; 	) or StyA2B (0.66 M; ●) measured at 340 nm (excitation
290 nm) during flavin titration with FAD to estimate dissociation
constants of apoenzyme-flavin complexes.
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different cofactor affinities (strong, Kd1  0.05  0.17 M; and
weak, Kd2  7.19  0.61 M). For StyA (Kd  21.2  2 M)
and StyB (Kd 2.3 0.3 M) from Pseudomonas sp. VLB120,
the reductase component had a higher affinity for FAD than
the oxygenase component (27). Thus, it might be argued
that the relatively strong interaction between StyA2B and
FAD is caused by the reductase domain and not by the
Rossmann fold of the oxygenase domain. This is further
supported by the fact that the related PheA2 reductase from
Geobacillus thermoglucosidasius binds FAD with nanomolar
affinity (20, 44).
StyA1 from R. opacus 1CP binds oxidized FAD (Kd  0.23 
0.06 M) two orders of magnitude better than StyA from
Pseudomonas sp. VLB120 (Kd  21.2  2 M; 27). Neverthe-
less, the affinity of StyA1 to FAD is consistent with the fact that
SMOs have a strong preference for binding FADH2 (19, 42).
For StyA from Pseudomonas putida S12, it was reported that
the reduced flavin cofactor binds about 8,000 times more
tightly than the oxidized form (42). Based on this and struc-
tural considerations, a kinetic mechanism was proposed in
which the reaction of oxygen with StyA-bound FADH2 pre-
cedes the binding of styrene. In the case of the StyA1/StyA2B
system, we cannot exclude another sequence of events, but
apparently, some transient interaction between the protein
partners is needed to promote the proper binding of FADH2
to StyA1. One driving force for this might be the anionic
nature of the isoalloxazine moiety of FADH2, which would
bring cofactor and substrate together, as observed with fla-
voprotein aromatic hydroxylases (11). StyA1 shows a signifi-
cant affinity for FAD and may bind FAD if no FADH2 is
transferred (Fig. 4b). Binding of the oxidized flavin cofactor
might be beneficial for the protein stability (7, 15), but it may
also inhibit the monooxygenase activity by competing with
FADH2 for the flavin binding site. The (transient) interaction
between StyA1 and StyA2B might change the affinity of StyA1
for FAD(H2). However, as noted above, it is more likely that
it supports the exchange and limits the uncoupling of epoxida-
tion (Table 2).
In conclusion, StyA1/StyA2B from Rhodococcus opacus 1CP
is a novel, unusual member of the family of two-component
flavin-dependent monooxygenases (10, 43). The raised hypoth-
esis of a functional interaction of both proteins was reinforced.
StyA1 was identified as the major monooxygenase, and StyA2B
turned out to function mainly as a FAD reductase with little
oxygenating side activity. The StyA1/StyA2B system has an
overall epoxidation activity of 0.24 U mg1, which competes
favorably with the activity of previously described SMOs (27,
45). Why has nature designed such a complex monooxygenase
system? It cannot be excluded that the occurrence of the
StyA2B fusion is a survival or intermediate from evolutionary
events. No activity data of a comparable system are available
yet. Only three sets of genes homologous to styA1-styA2B are
known. All are adjacently located in genomes of Gram-positive
actinobacteria (Arthrobacter, Nocardia, and Streptomyces) and
share 50 to 70% amino acid sequence similarities (40). Indeed,
the herein-described multifunctional monooxygenase StyA1/
StyA2B needs further investigation and is an attractive target
for optimization for biotechnological purposes.
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